sepsis/비만증

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

SUMMARY OF THE INVENTION The invention relates to pinitol and derivatives and metabolites thereof and compositions containing same for treating conditions associated with insulin resistance. These include disorders such as diabetes mellitus and its chronic complications; obesity; hyperlipidemias and

SUMMARY OF THE INVENTION The invention relates to pinitol and derivatives and metabolites thereof and compositions containing same for lowering plasma free fatty acids levels and for treating conditions associated with insulin resistance. These conditions associated with insulin resistance can

BACKGROUND All publications mentioned herein are cited for the purpose of familiarizing the reader with the background of the invention. Nothing herein is to be construed as an admission that these references are prior art in relation to the inventions described herein. Although Type 2 Diabetes

FIELD The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In

FIELD The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In

1. FIELD OF THE INVENTION The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with

FIELD The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In

1. FIELD OF THE INVENTION The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with

1. FIELD OF THE INVENTION The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with

TECHNICAL FIELD The present invention relates to a nitrogen-containing bicyclic compound or a pharmacologically acceptable salt thereof and a pharmaceutical composition comprising it as active ingredient. More specifically, the present invention relates to (1) a compound of formula (I) ##STR00002##

INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith: a) File name: 32681000038SEQ.txt; created 2-22-12, 1.36 KB in size. TECHNICAL FIELD OF THE

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising

TECHNICAL FIELD OF THE INVENTION The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising